327 related articles for article (PubMed ID: 16083704)
1. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
[TBL] [Abstract][Full Text] [Related]
2. Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans.
Marschall HU; Wagner M; Zollner G; Fickert P; Silbert D; Gustafsson U; Sahlin S; Trauner M
Digestion; 2012; 86(3):244-9. PubMed ID: 22964716
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
4. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
5. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
6. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
7. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
8. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
Duttala S; Tobi M; Dingell JD
Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
[No Abstract] [Full Text] [Related]
9. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Glantz A; Marschall HU; Lammert F; Mattsson LA
Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
[TBL] [Abstract][Full Text] [Related]
10. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
[TBL] [Abstract][Full Text] [Related]
11. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
Beuers U
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments.
Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA
Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689
[TBL] [Abstract][Full Text] [Related]
14. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
[TBL] [Abstract][Full Text] [Related]
16. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
17. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment.
Lucangioli SE; Castaño G; Contin MD; Tripodi VP
Ann Clin Biochem; 2009 Jan; 46(Pt 1):44-9. PubMed ID: 19103957
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Paumgartner G; Beuers U
Clin Liver Dis; 2004 Feb; 8(1):67-81, vi. PubMed ID: 15062194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
